Habtamu Biazin Kebede
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Habtamu Biazin Kebede has a total of 74 co-authors. Here are the top co-authors by number of shared publications:
- Tamrat Abebe
Department of Microbiology, Immunology, and Parasitology, Addis Ababa University, Addis Ababa, Ethiopia
5 shared publications - Ola Forslund
Department of Translational Medicine, Lund University, 680 40 Malmö, Sweden
4 shared publications - Adane Mihret
Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa 1165, Ethiopia
3 shared publications - Asmamaw Nitsuh Woreta
Department of Microbiology, Immunology and Parasitology, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia
3 shared publications - Christer Borgfeldt
Department of Obstetrics and Gynecology in Linköping, Department of Biomedical and Clinical Sciences, Linköping University, SE-58185, 580 02 Linköping, Sweden
3 shared publications - Mats Jerkeman
Skane University Hospital and Lund University, Lund, Sweden
3 shared publications
Latest Publications
- Open Access
- 3 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2243
Vaginal Cytokine Profiles Associated with High-Risk Human Papillomavirus, Sexually Transmitted Microbe Co-Detection, and Cervical Lesions
Persistent hrHPV infection is the necessary cause of cervical cancer, but local immune responses and sexually transmitted infections or genital mycoplasma may influence viral persistence and lesion progression. This study examined vaginal cytokine profiles according to hrHPV and sexually transmitted microbe (STM) detection and assessed their association with cervical lesions. Self-collected vaginal samples were obtained from 80 women classified into four mutually exclusive groups: hrHPV infection alone (n = 16), STM detection alone (n = 16), hrHPV/STM co-detections (n = 26), and negative controls (n = 22). Among 80 participants, 10 (13%) were women living with HIV. Detection of target organisms was performed using real-time PCR on a CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). Histological analysis included 33 women: 25 were women with normal histology or cervical intraepithelial neoplasia 1 (CIN1), and 8 women with CIN2+ lesions. Vaginal cytokine concentrations (pg/mL) were analyzed using the Invitrogen ProcartaPlex™ Multiplex Immunoassay (Vienna, Austria). Statistical analyses assessed group differences in cytokine levels. Women with hrHPV/STM showed significantly elevated levels of Eotaxin (p = 0.04), IL-2 (p = 0.045), IL-10 (p = 0.02), and IP-10 (p = 0.04) compared to negative controls. Elevated IL-2 (p = 0.016) was also observed in women with STMs alone; women with hrHPV infection showed lower IL-15 levels (p = 0.02). Higher concentrations of TNF-α (p = 0.04), IL-1β (p = 0.02), and EGF (p = 0.01) were associated with CIN2+ lesions. Women with hrHPV/sexually transmitted microbe co-detection showed higher levels of Eotaxin, IL-2, IL-10, and IP-10, and the association of hrHPV alone with lower IL-15 levels. The findings also show that higher levels of EGF, IL-1β, and TNF-α were associated with CIN2+ lesions.
- 3 October 2026
- Published by MDPI AG in Microorganisms
- Vol. 14 (10) , 2243
Open AccessVaginal Cytokine Profiles Associated with High-Risk Human Papillomavirus, Sexually Transmitted Microbe Co-Detection, and Cervical Lesions
Persistent hrHPV infection is the necessary cause of cervical cancer, but local immune responses and sexually transmitted infections or genital mycoplasma may influence viral persistence and lesion progression. This study examined vaginal cytokine profiles according to hrHPV and sexually transmitted microbe (STM) detection and assessed their association with cervical lesions. Self-collected vaginal samples were obtained from 80 women classified into four mutually exclusive groups: hrHPV infection alone (n = 16), STM detection alone (n = 16), hrHPV/STM co-detections (n = 26), and negative controls (n = 22). Among 80 participants, 10 (13%) were women living with HIV. Detection of target organisms was performed using real-time PCR on a CFX96 Real-Time PCR Detection System (Bio-Rad, Hercules, CA, USA). Histological analysis included 33 women: 25 were women with normal histology or cervical intraepithelial neoplasia 1 (CIN1), and 8 women with CIN2+ lesions. Vaginal cytokine concentrations (pg/mL) were analyzed using the Invitrogen ProcartaPlex™ Multiplex Immunoassay (Vienna, Austria). Statistical analyses assessed group differences in cytokine levels. Women with hrHPV/STM showed significantly elevated levels of Eotaxin (p = 0.04), IL-2 (p = 0.045), IL-10 (p = 0.02), and IP-10 (p = 0.04) compared to negative controls. Elevated IL-2 (p = 0.016) was also observed in women with STMs alone; women with hrHPV infection showed lower IL-15 levels (p = 0.02). Higher concentrations of TNF-α (p = 0.04), IL-1β (p = 0.02), and EGF (p = 0.01) were associated with CIN2+ lesions. Women with hrHPV/sexually transmitted microbe co-detection showed higher levels of Eotaxin, IL-2, IL-10, and IP-10, and the association of hrHPV alone with lower IL-15 levels. The findings also show that higher levels of EGF, IL-1β, and TNF-α were associated with CIN2+ lesions.
- Open Access
- 30 September 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (09) , 1331-1340
Prevalence of MRSA and associated factors among wound patients at Werabe Comprehensive Specialized Hospital, Ethiopia
Introduction: Staphylococcus aureus is a major global health threat due to its widespread distribution, ability to cause severe infections, and increasing antimicrobial resistance. It is responsible for a wide range of diseases, particularly skin and soft tissue infections, with wound infections being the most common. The emergence of methicillin-resistant S. aureus (MRSA) is of significant concern. However, local data on MRSA in wound infections remain limited. This study assessed the prevalence, antimicrobial susceptibility, and associated factors of MRSA among patients with wound infections at Werabe Comprehensive Specialized Hospital (WCSH). Methodology: A cross-sectional study was conducted from July 2023 to February 2024 involving 384 patients with wound infections. Wound swabs or pus samples were cultured on blood agar and mannitol salt agar. Identification of S. aureus was performed using standard biochemical tests, while MRSA detection used the cefoxitin disk diffusion method following CLSI guidelines. Data were collected using a semi-structured questionnaire, entered into Epi-info, and analyzed with SPSS. Logistic regression identified associations, with p < 0.05 considered significant. Results: Of 384 participants, 90 (23.4%) had S. aureus; of which 24 (26.7%) were MRSA. Most S. aureus isolates (87.8%) and all MRSA were resistant to penicillin but fully sensitive to linezolid. All MRSA and 31.1% of S. aureus isolates were multidrug resistant. Hospital stay > 72 hours was significantly associated with MRSA (AOR = 3.06, p = 0.031). Conclusions: There is a notable prevalence of MRSA with high multidrug resistance. Strengthening infection control, antimicrobial stewardship, and reducing prolonged hospital stays are recommended.
- 30 September 2026
- Published by Journal of Infection in Developing Countries in The Journal of Infection in Developing Countries
- Vol. 20 (09) , 1331-1340
Open AccessPrevalence of MRSA and associated factors among wound patients at Werabe Comprehensive Specialized Hospital, Ethiopia
Introduction: Staphylococcus aureus is a major global health threat due to its widespread distribution, ability to cause severe infections, and increasing antimicrobial resistance. It is responsible for a wide range of diseases, particularly skin and soft tissue infections, with wound infections being the most common. The emergence of methicillin-resistant S. aureus (MRSA) is of significant concern. However, local data on MRSA in wound infections remain limited. This study assessed the prevalence, antimicrobial susceptibility, and associated factors of MRSA among patients with wound infections at Werabe Comprehensive Specialized Hospital (WCSH). Methodology: A cross-sectional study was conducted from July 2023 to February 2024 involving 384 patients with wound infections. Wound swabs or pus samples were cultured on blood agar and mannitol salt agar. Identification of S. aureus was performed using standard biochemical tests, while MRSA detection used the cefoxitin disk diffusion method following CLSI guidelines. Data were collected using a semi-structured questionnaire, entered into Epi-info, and analyzed with SPSS. Logistic regression identified associations, with p < 0.05 considered significant. Results: Of 384 participants, 90 (23.4%) had S. aureus; of which 24 (26.7%) were MRSA. Most S. aureus isolates (87.8%) and all MRSA were resistant to penicillin but fully sensitive to linezolid. All MRSA and 31.1% of S. aureus isolates were multidrug resistant. Hospital stay > 72 hours was significantly associated with MRSA (AOR = 3.06, p = 0.031). Conclusions: There is a notable prevalence of MRSA with high multidrug resistance. Strengthening infection control, antimicrobial stewardship, and reducing prolonged hospital stays are recommended.
- Open Access
- 1 August 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-14
Performance Evaluation of Nasopharyngeal Swab Pooling to Improve SARS-CoV-2 Testing Capacity via Closed Real-Time RT‒PCR Assays
Background: The consistency of GeneXpert and Cobas RT-PCR assays for detecting SARS-CoV-2 in pooled versus individual samples remains uncertain. Sample pooling combines multiple patient samples into a single test reaction to increase efficiency. Only one study in Ethiopia has evaluated pooling performance for SARS-CoV-2 detection, but it failed to directly compare these two widely used diagnostic tests. Purpose: This study evaluated the performance of the Cepheid Xpert® Xpress (Xpert) and Roche Cobas® (Cobas) SARS-CoV-2 assays for SARS-CoV-2 detection in pooled nasopharyngeal swab samples. Patients and Methods: The study used a cross-sectional study design on 50 confirmed SARS-CoV-2-positive samples grouped by their Cycle Threshold (CT) values. These samples were pooled with SARS-CoV-2-negative samples and tested using both assays. A total of 200 pooled samples were tested. Results: Of the 200 poled samples tested, 91.0% and 81.0% tested positive with Xpert and Cobas, respectively, with an overall agreement of 89% (κ=0.552). Strong correlation was observed between the CT values of the initial individual samples and the pooled samples for both assays. In pool-4 and pool-6, the Xpert assay detected 94.0% of positives, while Cobas assay detected 82.0%. Overall, 80.5% of pooled samples were positive and 8.5% were negative with both assays (overall concordance of 89.0%), Percent Positive Agreement of 93.6%, and Negative Agreement of 60.7%. Conclusion: Overall, these findings suggest that implementing sample pooling can be particularly beneficial in low-resource settings where testing resources are limited, enabling an increase in overall testing capacity. Xpert assay performed effectively for pooling up to six samples, whereas the Cobas assay showed reduced sensitivity, especially with low viral loads. This implies that pooling of nasopharyngeal samples from asymptomatic individuals may be missed by the Cobas assay, underscoring the importance of considering pool size, viral load and assay choices when implementing pooled SARS-CoV-2 testing.
- 1 August 2026
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 19, 1-14
Open AccessPerformance Evaluation of Nasopharyngeal Swab Pooling to Improve SARS-CoV-2 Testing Capacity via Closed Real-Time RT‒PCR Assays
Background: The consistency of GeneXpert and Cobas RT-PCR assays for detecting SARS-CoV-2 in pooled versus individual samples remains uncertain. Sample pooling combines multiple patient samples into a single test reaction to increase efficiency. Only one study in Ethiopia has evaluated pooling performance for SARS-CoV-2 detection, but it failed to directly compare these two widely used diagnostic tests. Purpose: This study evaluated the performance of the Cepheid Xpert® Xpress (Xpert) and Roche Cobas® (Cobas) SARS-CoV-2 assays for SARS-CoV-2 detection in pooled nasopharyngeal swab samples. Patients and Methods: The study used a cross-sectional study design on 50 confirmed SARS-CoV-2-positive samples grouped by their Cycle Threshold (CT) values. These samples were pooled with SARS-CoV-2-negative samples and tested using both assays. A total of 200 pooled samples were tested. Results: Of the 200 poled samples tested, 91.0% and 81.0% tested positive with Xpert and Cobas, respectively, with an overall agreement of 89% (κ=0.552). Strong correlation was observed between the CT values of the initial individual samples and the pooled samples for both assays. In pool-4 and pool-6, the Xpert assay detected 94.0% of positives, while Cobas assay detected 82.0%. Overall, 80.5% of pooled samples were positive and 8.5% were negative with both assays (overall concordance of 89.0%), Percent Positive Agreement of 93.6%, and Negative Agreement of 60.7%. Conclusion: Overall, these findings suggest that implementing sample pooling can be particularly beneficial in low-resource settings where testing resources are limited, enabling an increase in overall testing capacity. Xpert assay performed effectively for pooling up to six samples, whereas the Cobas assay showed reduced sensitivity, especially with low viral loads. This implies that pooling of nasopharyngeal samples from asymptomatic individuals may be missed by the Cobas assay, underscoring the importance of considering pool size, viral load and assay choices when implementing pooled SARS-CoV-2 testing.
- Open Access
- 18 February 2025
- Published by MDPI AG in Preprints.org
Cytokine Profiling in Vaginal Specimens from Asymptomatic Women with Human Papillomavirus and/or Sexually Transmitted Infections
Background: The primary cause of cervical cancer is the high-risk human papillomavirus (hrHPV); the infection patterns may vary depending on the state of the vaginal immune system. Sexually transmitted infections (STIs) such as gonorrhea, trichomoniasis, and chlamydia can alter the local immune response, which in turn may affect the persistence and progression rate of hrHPV infections. The objective of this study was to compare cytokine levels from vaginal specimens collected from hrHPV positive, STI positive, and healthy controls, and to explore correlations with clinical parameters. Methods: Vaginal samples were collected from women diagnosed with hrHPV, asymptomatic STIs, and healthy controls. HrHPV and STIs status were confirmed through multiplex real time PCR. Vaginal cytokines and various growth factors were analyzed by Invitrogen ProcartaPlex™ Multiplex Immunoassay. Statistical analyses were performed to compare cytokine levels across different groups and to explore correlations with clinical parameters. Results: Women having STIs and hrHPV coinfection(n=26) had increased median concentration levels of Eotaxin (P=0.04), IL-2 (P=0.01), IL-10 (P=0.02), and IP-10 (P=0.04) compared to the control groups(n=22). Asymptomatic women with STIs (n=16) exhibited a distinct cytokine profile characterized by elevated levels of IL-2 (P=0.02) compared with control groups. Women with hrHPV(n=16) had lower levels of IL-15 (P=0.02) compared to controls. The median concentration levels of TNF-α (P=0.04), IL-1β (P=0.02), and EGF (P=0.01) were significantly greater in ≥CIN2+(n=8) than ≤CIN1(n=25). The area under the curve (AUC) of EGF, IL-1β, and the combination of EGF+IL-1β +TNF-α was good predictor for high-grade cervical lesions. Conclusion: The cytokine profiling revealed significant alterations in the vaginal immune environment in women with asymptomatic STIs and co-infection with hrHPV. The findings suggest that an inflammatory response in hrHPV infection may be modulated by co-existing STIs, potentially influencing disease progression. Elevated levels of EGF, IL-1β, and TNF-α in vaginal swabs suggest an inflammatory and proliferative environment that can contribute to the development and progression of cervical dysplasia.
- 18 February 2025
- Published by MDPI AG in Preprints.org
Open AccessCytokine Profiling in Vaginal Specimens from Asymptomatic Women with Human Papillomavirus and/or Sexually Transmitted Infections
Background: The primary cause of cervical cancer is the high-risk human papillomavirus (hrHPV); the infection patterns may vary depending on the state of the vaginal immune system. Sexually transmitted infections (STIs) such as gonorrhea, trichomoniasis, and chlamydia can alter the local immune response, which in turn may affect the persistence and progression rate of hrHPV infections. The objective of this study was to compare cytokine levels from vaginal specimens collected from hrHPV positive, STI positive, and healthy controls, and to explore correlations with clinical parameters. Methods: Vaginal samples were collected from women diagnosed with hrHPV, asymptomatic STIs, and healthy controls. HrHPV and STIs status were confirmed through multiplex real time PCR. Vaginal cytokines and various growth factors were analyzed by Invitrogen ProcartaPlex™ Multiplex Immunoassay. Statistical analyses were performed to compare cytokine levels across different groups and to explore correlations with clinical parameters. Results: Women having STIs and hrHPV coinfection(n=26) had increased median concentration levels of Eotaxin (P=0.04), IL-2 (P=0.01), IL-10 (P=0.02), and IP-10 (P=0.04) compared to the control groups(n=22). Asymptomatic women with STIs (n=16) exhibited a distinct cytokine profile characterized by elevated levels of IL-2 (P=0.02) compared with control groups. Women with hrHPV(n=16) had lower levels of IL-15 (P=0.02) compared to controls. The median concentration levels of TNF-α (P=0.04), IL-1β (P=0.02), and EGF (P=0.01) were significantly greater in ≥CIN2+(n=8) than ≤CIN1(n=25). The area under the curve (AUC) of EGF, IL-1β, and the combination of EGF+IL-1β +TNF-α was good predictor for high-grade cervical lesions. Conclusion: The cytokine profiling revealed significant alterations in the vaginal immune environment in women with asymptomatic STIs and co-infection with hrHPV. The findings suggest that an inflammatory response in hrHPV infection may be modulated by co-existing STIs, potentially influencing disease progression. Elevated levels of EGF, IL-1β, and TNF-α in vaginal swabs suggest an inflammatory and proliferative environment that can contribute to the development and progression of cervical dysplasia.
- 14 February 2025
- Published by Wiley in International Journal of Cancer
- Vol. 156 (10) , 1995-2009
High‐risk human papillomavirus genotypes in previously unscreened reproductive‐age women in Ethiopia: A community‐based cohort study
High‐risk human papillomavirus (hrHPV) genotype is needed for adequate cervical cancer screening and HPV vaccination program evaluation as recommended by different guidelines. We aimed to assess the rate of HPV infection and HPV genotype distribution using vaginal self‐sampling in a cohort of unscreened reproductive‐age women in Ethiopia. A community‐based cohort study was conducted with women aged 23–46 living in Adama, Ethiopia. A total of 885 self‐collected vaginal swabs were obtained and tested for hrHPV genotypes with the real‐time polymerase chain reaction technique. The overall hrHPV prevalence was 21.1% (187/885, 95% confidence interval [CI]: 18.5–24.0). Among women living with human immunodeficiency virus, 46% (30/56) (95% CI: 33.7–59) were hrHPV positive compared with 19% (157/820) (95% CI: 16.2–22) of human immunodeficiency virus‐negative women. The most frequent genotypes were HPV16 (3.1%), HPV51 (3.1%), HPV35 (2.6%), HPV56 (2.6%), HPV52 (2.4%), HPV31 (2.5%), and HPV39 (2.5%). Among the 187 HPV‐positive women in self‐samples, HPV 16/18 was found in 21% (39), HPV 16/18/45 was found in 24% (44), and HPV 16/18/31/33/45/52/58 was prevalent in 56% (104). Out of 116 biopsies, 7% (8) had cervical intraepithelial lesions and worse identified. Of these eight cervical intraepithelial lesions and worse patients, only 25% tested positive for HPV‐16; none tested positive for HPV‐18 or 45. One out of five women tested positive for hrHPV genotypes. Other HPV genotypes not covered by the quadrivalent HPV vaccine but associated with clinically significant cervical high‐grade lesions or cancer were detected in 75%. It is more effective to prevent cervical cancer by switching to the nine‐valent HPV vaccine.
- 14 February 2025
- Published by Wiley in International Journal of Cancer
- Vol. 156 (10) , 1995-2009
High‐risk human papillomavirus genotypes in previously unscreened reproductive‐age women in Ethiopia: A community‐based cohort study
High‐risk human papillomavirus (hrHPV) genotype is needed for adequate cervical cancer screening and HPV vaccination program evaluation as recommended by different guidelines. We aimed to assess the rate of HPV infection and HPV genotype distribution using vaginal self‐sampling in a cohort of unscreened reproductive‐age women in Ethiopia. A community‐based cohort study was conducted with women aged 23–46 living in Adama, Ethiopia. A total of 885 self‐collected vaginal swabs were obtained and tested for hrHPV genotypes with the real‐time polymerase chain reaction technique. The overall hrHPV prevalence was 21.1% (187/885, 95% confidence interval [CI]: 18.5–24.0). Among women living with human immunodeficiency virus, 46% (30/56) (95% CI: 33.7–59) were hrHPV positive compared with 19% (157/820) (95% CI: 16.2–22) of human immunodeficiency virus‐negative women. The most frequent genotypes were HPV16 (3.1%), HPV51 (3.1%), HPV35 (2.6%), HPV56 (2.6%), HPV52 (2.4%), HPV31 (2.5%), and HPV39 (2.5%). Among the 187 HPV‐positive women in self‐samples, HPV 16/18 was found in 21% (39), HPV 16/18/45 was found in 24% (44), and HPV 16/18/31/33/45/52/58 was prevalent in 56% (104). Out of 116 biopsies, 7% (8) had cervical intraepithelial lesions and worse identified. Of these eight cervical intraepithelial lesions and worse patients, only 25% tested positive for HPV‐16; none tested positive for HPV‐18 or 45. One out of five women tested positive for hrHPV genotypes. Other HPV genotypes not covered by the quadrivalent HPV vaccine but associated with clinically significant cervical high‐grade lesions or cancer were detected in 75%. It is more effective to prevent cervical cancer by switching to the nine‐valent HPV vaccine.
- Open Access
- 3 October 2024
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 34 (11) , 1691-1697
Comparing visual inspection with acetic acid, with and without Lugol’s Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial
Background Most women who are high-risk human papilloma virus (hrHPV) positive in a cervical cancer screening test will spontaneously heal from their infection. Visual inspection with acetic acid (VIA) is recommended by the World Health Organization as a triage test for cervical screening, however its accuracy as a triage test has been questioned. In this study, we aimed to examine the sensitivity and specificity of VIA with and without Lugol’s iodine as a triage test to detect cervical intraepithelial neoplasia (CIN2+) among women who tested positive for hrHPV after self-sampling. Method This two-armed randomized controlled trial (RCT) took place in Adama, Ethiopia. The women who tested positive for vaginal hrHPV (Anyplex ΙΙ, Seegene) after self-sampling were randomized to VIA with or without iodine and appointed to a midwife-led clinic. The result of the triage test was categorized as positive, negative, suspicion of cancer or inconclusive, and treated accordingly. Cervical biopsies were collected from women who were hrHPV positive to serve as a gold standard. Results 22.4% (197/878) of women tested hrHPV positive. Sensitivity and specificity for VIA to detect CIN2+was 25.0% (95% CI 0.6 to 80.0) and 82.7% (95% CI 69.7 to 91.8), respectively. For VIA with iodine, the sensitivity was 50.0% (95% CI 0.7 to 93.2) and the specificity 86.3% (95% CI 71.4 to 93.0). The difference between the two methods was not statistically significant, p=0.5. The odds of detecting CIN2+ was 5.4 times higher if positive for VIA with iodine compared with a negative result. For VIA without iodine, the odds of detecting CIN2+ was 1.6 compared with a negative result. The odds of detecting CIN2+ was 6.4 times higher if the women were HIV positive than for those who were HIV negative. Conclusion VIA with iodine improved detection of CIN2+ in women who were hrHPV DNA positive but was not significantly better than VIA alone. Trial registration number NCT05125380.
- 3 October 2024
- Published by Elsevier in International Journal of Gynecological Cancer
- Vol. 34 (11) , 1691-1697
Open AccessComparing visual inspection with acetic acid, with and without Lugol’s Iodine for triage of HPV self-sample positive women in Ethiopia: a randomized controlled trial
Background Most women who are high-risk human papilloma virus (hrHPV) positive in a cervical cancer screening test will spontaneously heal from their infection. Visual inspection with acetic acid (VIA) is recommended by the World Health Organization as a triage test for cervical screening, however its accuracy as a triage test has been questioned. In this study, we aimed to examine the sensitivity and specificity of VIA with and without Lugol’s iodine as a triage test to detect cervical intraepithelial neoplasia (CIN2+) among women who tested positive for hrHPV after self-sampling. Method This two-armed randomized controlled trial (RCT) took place in Adama, Ethiopia. The women who tested positive for vaginal hrHPV (Anyplex ΙΙ, Seegene) after self-sampling were randomized to VIA with or without iodine and appointed to a midwife-led clinic. The result of the triage test was categorized as positive, negative, suspicion of cancer or inconclusive, and treated accordingly. Cervical biopsies were collected from women who were hrHPV positive to serve as a gold standard. Results 22.4% (197/878) of women tested hrHPV positive. Sensitivity and specificity for VIA to detect CIN2+was 25.0% (95% CI 0.6 to 80.0) and 82.7% (95% CI 69.7 to 91.8), respectively. For VIA with iodine, the sensitivity was 50.0% (95% CI 0.7 to 93.2) and the specificity 86.3% (95% CI 71.4 to 93.0). The difference between the two methods was not statistically significant, p=0.5. The odds of detecting CIN2+ was 5.4 times higher if positive for VIA with iodine compared with a negative result. For VIA without iodine, the odds of detecting CIN2+ was 1.6 compared with a negative result. The odds of detecting CIN2+ was 6.4 times higher if the women were HIV positive than for those who were HIV negative. Conclusion VIA with iodine improved detection of CIN2+ in women who were hrHPV DNA positive but was not significantly better than VIA alone. Trial registration number NCT05125380.
- Open Access
- 11 January 2024
- Published by Elsevier in International Journal of Africa Nursing Sciences
- Vol. 20
Determinants and knowledge of men on obstetric danger signs: A community-based cross-sectional study in Debretabor, Ethiopia
- 11 January 2024
- Published by Elsevier in International Journal of Africa Nursing Sciences
- Vol. 20
Open AccessDeterminants and knowledge of men on obstetric danger signs: A community-based cross-sectional study in Debretabor, Ethiopia
- Open Access
- 31 August 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 987487
Bacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia
Introduction: Infected diabetic foot ulcer (IDFU) is a worldwide problem associated with diabetes mellitus. It could lead from soft tissue infection to bone infection and is a leading cause of lower limb amputation. Gram-negative and Gram-positive bacteria, including anaerobic bacteria and fungi, are considered potential causes of infection. The early diagnosis of DFU infection and appropriate treatment based on the identification of the pathogens and their antimicrobial susceptibility pattern is important for good prognosis. Therefore, the purpose of this study was to isolate the bacteria that infect foot ulcers in selected Hospitals and determine their antimicrobial resistance profile.Method: An institutional-based multicenter, cross-sectional study was conducted in selected Hospitals in Addis Ababa, Ethiopia, from November 2020 to May 2021. A sterile swab was used to collect samples from the foot ulcer and a sterile needle to collect pus. Isolates were identified by culture, Gram-staining, and a series of biochemical tests. For each bacterial species identified, the antibiotic profiling was determined by the Kirby-Bauer disk diffusion method.Results: one hundred and twenty-seven pathogenic bacteria were isolated from samples taken from 130 patients with a diabetic foot ulcer. Sixty-eight percent had growth of multiple microorganisms. Two-thirds (66.7%) of the isolates were gram-negative bacteria. The predominant bacterial species were S. aureus 25.19% (32/127), Pseudomonas species 18.89% (24/127), and Escherichia coli 16.53% (21/127). Overall, 92.9% (118/127) of the isolates were identified as multi-drug resistant. Gram-positive isolates were susceptible to chloramphenicol, clindamycin, and amikacin. Gram-negative isolates were also sensitive to chloramphenicol, aztreonam, and amikacin.Conclusion: The majority of bacteria isolated from patients presenting with Diabetic foot ulcer infections were found to be multi-drug resistant in the study sites of the current study. The results demonstrate the importance of timely identification of infection of diabetic foot ulcers, proper sample collection for identification of the pathogens and for determining their antibiotic susceptibility pattern before initiating antimicrobial treatment
- 31 August 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 987487
Open AccessBacterial isolates from diabetic foot ulcers and their antimicrobial resistance profile from selected hospitals in Addis Ababa, Ethiopia
Introduction: Infected diabetic foot ulcer (IDFU) is a worldwide problem associated with diabetes mellitus. It could lead from soft tissue infection to bone infection and is a leading cause of lower limb amputation. Gram-negative and Gram-positive bacteria, including anaerobic bacteria and fungi, are considered potential causes of infection. The early diagnosis of DFU infection and appropriate treatment based on the identification of the pathogens and their antimicrobial susceptibility pattern is important for good prognosis. Therefore, the purpose of this study was to isolate the bacteria that infect foot ulcers in selected Hospitals and determine their antimicrobial resistance profile.Method: An institutional-based multicenter, cross-sectional study was conducted in selected Hospitals in Addis Ababa, Ethiopia, from November 2020 to May 2021. A sterile swab was used to collect samples from the foot ulcer and a sterile needle to collect pus. Isolates were identified by culture, Gram-staining, and a series of biochemical tests. For each bacterial species identified, the antibiotic profiling was determined by the Kirby-Bauer disk diffusion method.Results: one hundred and twenty-seven pathogenic bacteria were isolated from samples taken from 130 patients with a diabetic foot ulcer. Sixty-eight percent had growth of multiple microorganisms. Two-thirds (66.7%) of the isolates were gram-negative bacteria. The predominant bacterial species were S. aureus 25.19% (32/127), Pseudomonas species 18.89% (24/127), and Escherichia coli 16.53% (21/127). Overall, 92.9% (118/127) of the isolates were identified as multi-drug resistant. Gram-positive isolates were susceptible to chloramphenicol, clindamycin, and amikacin. Gram-negative isolates were also sensitive to chloramphenicol, aztreonam, and amikacin.Conclusion: The majority of bacteria isolated from patients presenting with Diabetic foot ulcer infections were found to be multi-drug resistant in the study sites of the current study. The results demonstrate the importance of timely identification of infection of diabetic foot ulcers, proper sample collection for identification of the pathogens and for determining their antibiotic susceptibility pattern before initiating antimicrobial treatment
- Open Access
- 11 August 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 4435-4441
Prevalence of Extended-Spectrum β-Lactamase and Carbapenemase Producers of Gram-Negative Bacteria, and Methicillin-Resistant Staphylococcus aureus in Isolates from Diabetic Foot Ulcer Patients in Ethiopia
Background: Infectious diabetic foot ulcers (IDFU) are a widespread health issue that affects people all over the world. IDFU, like other medical disorders, can have negative implications if drug resistance develops. Clinicians will be able to choose the optimal antibiotics to treat impacted patients based on the antibiotic susceptibility pattern of bacterial strains. In this project, we attempted to evaluate the levels of extended-spectrum beta-lactamase (ESBL), carbapenemase, and MRSA in patients with diabetic foot ulcers. Methods: A sterile swab was used to collect a sample from the leg ulcer, while a sterile needle was used to collect the aspirated pus. Bacteria identification and antibiotic susceptibility tests are carried out based on conventional bacterial culture. The double-disc inactivation method and modified carbapenem (meropenem) were used to screen the production of ESBL and carbapenemase. Results: Of the 76 isolates tested, 53.9% (41/76) were phenotypically ESBL producers. K. pneumoniae 75% (6/8), Acinetobacter species 75% (9/12), Serratia species 75% (3/4), Pseudomonas species 64.3% (14/9), E. coli 57.8% (11/19), Citrobacter species 50% (2/4) and Proteus mirabilis 25% (1/4) had the highest frequency of ESBL production. Of the 68 GNB isolates tested, 27.9% (19/68) were carbapenemase-producing organisms. K. pneumoniae 62.5% (5/8), Serratia 50% (3/6), Acinetobacter species 40% (4/10), Pseudomonas species 23.5% (4/17) and E. coli 15.8% (3/19) are the top five major carbapenemase producers. In this study, 32 isolates of Staphylococcus aureus were tested for methicillin resistance. Among them, 81.3% (26/32) were methicillin-resistant Staphylococcus aureus (MRSA), and 18.7% (6/32) of the remaining isolates were methicillin-sensitive Staphylococcus aureus (MSSA). Conclusion: The result draws attention to the management of diabetic foot ulcer infections based on the results of microbiological analysis and drug susceptibility testing.
- 11 August 2022
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 4435-4441
Open AccessPrevalence of Extended-Spectrum β-Lactamase and Carbapenemase Producers of Gram-Negative Bacteria, and Methicillin-Resistant Staphylococcus aureus in Isolates from Diabetic Foot Ulcer Patients in Ethiopia
Background: Infectious diabetic foot ulcers (IDFU) are a widespread health issue that affects people all over the world. IDFU, like other medical disorders, can have negative implications if drug resistance develops. Clinicians will be able to choose the optimal antibiotics to treat impacted patients based on the antibiotic susceptibility pattern of bacterial strains. In this project, we attempted to evaluate the levels of extended-spectrum beta-lactamase (ESBL), carbapenemase, and MRSA in patients with diabetic foot ulcers. Methods: A sterile swab was used to collect a sample from the leg ulcer, while a sterile needle was used to collect the aspirated pus. Bacteria identification and antibiotic susceptibility tests are carried out based on conventional bacterial culture. The double-disc inactivation method and modified carbapenem (meropenem) were used to screen the production of ESBL and carbapenemase. Results: Of the 76 isolates tested, 53.9% (41/76) were phenotypically ESBL producers. K. pneumoniae 75% (6/8), Acinetobacter species 75% (9/12), Serratia species 75% (3/4), Pseudomonas species 64.3% (14/9), E. coli 57.8% (11/19), Citrobacter species 50% (2/4) and Proteus mirabilis 25% (1/4) had the highest frequency of ESBL production. Of the 68 GNB isolates tested, 27.9% (19/68) were carbapenemase-producing organisms. K. pneumoniae 62.5% (5/8), Serratia 50% (3/6), Acinetobacter species 40% (4/10), Pseudomonas species 23.5% (4/17) and E. coli 15.8% (3/19) are the top five major carbapenemase producers. In this study, 32 isolates of Staphylococcus aureus were tested for methicillin resistance. Among them, 81.3% (26/32) were methicillin-resistant Staphylococcus aureus (MRSA), and 18.7% (6/32) of the remaining isolates were methicillin-sensitive Staphylococcus aureus (MSSA). Conclusion: The result draws attention to the management of diabetic foot ulcer infections based on the results of microbiological analysis and drug susceptibility testing.